Detalhe da pesquisa
1.
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70.
Clin Infect Dis
; 74(8): 1459-1467, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34283213
2.
Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine: Persistence and Anamnestic Response to Additional Doses Administered 10 Years After Primary Vaccination.
J Infect Dis
; 224(12): 2025-2034, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32502272
3.
No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial.
Hum Vaccin Immunother
; 20(1): 2327736, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513689
4.
The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials.
Hum Vaccin Immunother
; 17(7): 2050-2057, 2021 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33606577